GABAergic control of depression-related brain states

Advances in Pharmacology

Volumn 73, Issue , 2015, Pages 97-144

  Luscher, Bernhard ^a,b   Fuchs, Thomas ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Antidepressant drug action; Anxiety; BDNF; Excitatory inhibitory balance; GABA; Hippocampal neurogenesis; Major depressive disorder

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CHLORIDE; GLUTAMIC ACID; ANTIDEPRESSANT AGENT;

ARTICLE; CONCENTRATION (PARAMETERS); DISEASE MODEL; GABAERGIC TRANSMISSION; HERITABILITY; HOMEOSTASIS; HUMAN; INTERNEURON; MAJOR DEPRESSION; NEUROTROPISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; ANIMAL; BRAIN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; RECEPTORS, GABA-A; SYNAPTIC TRANSMISSION;

EID: 84921691547     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/bs.apha.2014.11.003     Document Type: Chapter

References (325)

1. Aguado F., Carmona M.A., Pozas E., Aguilo A., Martinez-Guijarro F.J., Alcantara S., et al. BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2. Development 2003, 130(7):1267-1280.
2. Aihara M., Ida I., Yuuki N., Oshima A., Kumano H., Takahashi K., et al. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Research 2007, 155(3):245-256.
3. Aimone J.B., Deng W., Gage F.H. Resolving new memories: A critical look at the dentate gyrus, adult neurogenesis, and pattern separation. Neuron 2011, 70(4):589-596.
4. Akana S.F., Chu A., Soriano L., Dallman M.F. Corticosterone exerts site-specific and state-dependent effects in prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, insulin and fat depots. Journal of Neuroendocrinology 2001, 13(7):625-637.
5. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Press, Washington, DC, (Text revision). 4th ed.
6. Angst J., Merikangas K.R. Multi-dimensional criteria for the diagnosis of depression. Journal of Affective Disorders 2001, 62(1-2):7-15.
7. Arnsten A.F. Stress signalling pathways that impair prefrontal cortex structure and function. Nature Reviews. Neuroscience 2009, 10(6):410-422.
8. Aukes M.F., Laan W., Termorshuizen F., Buizer-Voskamp J.E., Hennekam E.A., Smeets H.M., et al. Familial clustering of schizophrenia, bipolar disorder, and major depressive disorder. Genetics in Medicine 2012, 14(3):338-341.
9. Baldwin D.S., Evans D.L., Hirschfeld R.M., Kasper S. Can we distinguish anxiety from depression?. Psychopharmacology Bulletin 2002, 36(Suppl. 2):158-165.
10. Bale T.L., Baram T.Z., Brown A.S., Goldstein J.M., Insel T.R., McCarthy M.M., et al. Early life programming and neurodevelopmental disorders. Biological Psychiatry 2010, 68(4):314-319.
11. Banerjee R., Ghosh A.K., Ghosh B., Bhattacharyya S., Mondal A.C. Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: An analysis in human postmortem brain. Clinical Medicine Insights: Pathology 2013, 6:1-11.
12. Bauer M., Whybrow P.C., Angst J., Versiani M., Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World Journal of Biological Psychiatry 2002, 3(1):5-43. World Federation of Societies Biol Psychiat Task Force on Treatment Guidelines for Unipolar Depressive Disorders.
13. Bell-McGinty S., Butters M.A., Meltzer C.C., Greer P.J., Reynolds C.F., Becker J.T. Brain morphometric abnormalities in geriatric depression: Long-term neurobiological effects of illness duration. The American Journal of Psychiatry 2002, 159(8):1424-1427.
14. Ben-Ari, Y. (2013). The developing cortex. In M. L. Olivier Dulac & B. S. Harvey (Eds.), Handbook of clinical neurology (pp. 417-426). Elsevier.
15. Ben-Ari Y., Khalilov I., Kahle K.T., Cherubini E. The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. The Neuroscientist 2012, 18(5):467-486.
16. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., et al. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 2000, 47(4):351-354.
17. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311(5762):864-868.
18. Beurel E., Song L., Jope R.S. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Molecular Psychiatry 2011, 16(11):1068-1070.
19. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. The American Journal of Psychiatry 2004, 161(2):368-370.
20. Bhattacharyya S., Puri S., Miledi R., Panicker M.M. Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(22):14470-14475.
21. Birkenhager T.K., Moleman P., Nolen W.A. Benzodiazepines for depression? A review of the literature. International Clinical Psychopharmacology 1995, 10(3):181-195.
22. Blackwood D.H., Pickard B.J., Thomson P.A., Evans K.L., Porteous D.J., Muir W.J. Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotoxicity Research 2007, 11(1):73-83.
23. Bohacek J., Farinelli M., Mirante O., Steiner G., Gapp K., Coiret G., et al. Pathological brain plasticity and cognition in the offspring of males subjected to postnatal traumatic stress. Molecular Psychiatry 2014, Advance online publication. 10.1038/mp.2014.80.
24. A receptor activation, calcium influx and CaMKII and erk1/2 pathways. Journal of Neurochemistry 2003, 84(6):1411-1420.
25. Bos R., Sadlaoud K., Boulenguez P., Buttigieg D., Liabeuf S., Brocard C., et al. Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(1):348-353.
26. Bremne J.D., Vermetten E. Stress and development: Behavioral and biological consequences. Development and Psychopathology 2001, 13(3):473-489.
27. A receptors: Their function in the CNS and implications for disease. Neuron 2012, 73(1):23-34.
28. Brown M.T., Tan K.R., O'Connor E.C., Nikonenko I., Muller D., Luscher C. Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature 2012, 492(7429):452-456.
29. Bunney W.E., Davis J.M. Norepinephrine in depressive reactions. A review. Archives of General Psychiatry 1965, 13(6):483-494.
30. Calfa G., Bussolino D., Molina V.A. Involvement of the lateral septum and the ventral hippocampus in the emotional sequelae induced by social defeat: Role of glucocorticoid receptors. Behavioural Brain Research 2007, 181(1):23-34.
31. Carlen M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Molecular Psychiatry 2012, 17(5):537-548.
32. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314(5796):140-143.
33. Chen J., Li X., McGue M. The interacting effect of the BDNF Val66Met polymorphism and stressful life events on adolescent depression is not an artifact of gene-environment correlation: Evidence from a longitudinal twin study. Journal of Child Psychology and Psychiatry 2013, 54(10):1066-1073.
34. Chen A.I., Nguyen C.N., Copenhagen D.R., Badurek S., Minichiello L., Ranscht B., et al. TrkB (tropomyosin-related kinase B) controls the assembly and maintenance of GABAergic synapses in the cerebellar cortex. Journal of Neuroscience 2011, 31(8):2769-2780.
35. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. Journal of Neuroscience 2004, 24(18):4401-4411.
36. Chew M.L., Mulsant B.H., Pollock B.G., Lehman M.E., Greenspan A., Mahmoud R.A., et al. Anticholinergic activity of 107 medications commonly used by older adults. Journal of American Geriatrics Society 2008, 56(7):1333-1341.
37. Choudary P.V., Molnar M., Evans S.J., Tomita H., Li J.Z., Vawter M.P., et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(43):15653-15658.
38. Clelland C.D., Choi M., Romberg C., Clemenson G.D., Fragniere A., Tyers P., et al. A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 2009, 325(5937):210-213.
39. Clerc G.E., Ruimy P., Verdeau-Palles J. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. International Clinical Psychopharmacology 1994, 9(3):139-143.
40. Cobb J.A., Simpson J., Mahajan G.J., Overholser J.C., Jurjus G.J., Dieter L., et al. Hippocampal volume and total cell numbers in major depressive disorder. Journal of Psychiatric Research 2013, 47(3):299-306.
41. Cole J., Costafreda S.G., McGuffin P., Fu C.H. Hippocampal atrophy in first episode depression: A meta-analysis of magnetic resonance imaging studies. Journal of Affective Disorders 2011, 134(1-3):483-487.
42. A receptors influences receptor trafficking and neurosteroid actions. Psychopharmacology 2014, 231(17):3453-3465.
43. Coppen A. The biochemistry of affective disorders. The British Journal of Psychiatry 1967, 113(504):1237-1264.
44. Crane G.E. Cycloserine as an antidepressant agent. The American Journal of Psychiatry 1959, 115(11):1025-1026.
45. A-receptor clustering results in enhanced anxiety and a bias for threat cues. Nature Neuroscience 1999, 2(9):833-839.
46. Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee S.H., Ripke S., Neale B.M., Faraone S.V., Purcell S.M., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics 2013, 45(9):984-994.
47. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: Evidence for a relay in the bed nucleus of the stria terminalis. Journal of Comparative Neurology 1993, 332(1):1-20.
48. Curley A.A., Eggan S.M., Lazarus M.S., Huang Z.J., Volk D.W., Lewis D.A. Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: Implications for schizophrenia. Neurobiology of Disease 2013, 50:179-186.
49. D'Addario C., Dell'Osso B., Galimberti D., Palazzo M.C., Benatti B., Di Francesco A., et al. Epigenetic modulation of BDNF gene in patients with major depressive disorder. Biological Psychiatry 2013, 73(2):e6-7.
50. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews. Neuroscience 2008, 9(1):46-56.
51. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62(4):479-493.
52. de Boer T. The pharmacologic profile of mirtazapine. Journal of Clinical Psychiatry 1996, 57(Suppl. 4):19-25.
53. Dejanovic B., Schwarz G. Neuronal nitric oxide synthase-dependent S-nitrosylation of gephyrin regulates gephyrin clustering at GABAergic synapses. Journal of Neuroscience 2014, 34(23):7763-7768.
54. Dejanovic B., Semtner M., Ebert S., Lamkemeyer T., Neuser F., Luscher B., et al. Palmitoylation of gephyrin controls receptor clustering and plasticity of GABAergic synapses. PLoS Biology 2014, 12(7):e1001908.
55. Dekeyne A., Mannoury la Cour C., Gobert A., Brocco M., Lejeune F., Serres F., et al. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology 2008, 199(4):549-568.
56. Deschwanden A., Karolewicz B., Feyissa A.M., Treyer V., Ametamey S.M., Johayem A., et al. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. The American Journal of Psychiatry 2011, 168(7):727-734.
57. Dias B.G., Ressler K.J. Parental olfactory experience influences behavior and neural structure in subsequent generations. Nature Neuroscience 2014, 17(1):89-96.
58. Diaz S.L., Narboux-Neme N., Trowbridge S., Scotto-Lomassese S., Kleine Borgmann F.B., Jessberger S., et al. Paradoxical increase in survival of newborn neurons in the dentate gyrus of mice with constitutive depletion of serotonin. The European Journal of Neuroscience 2013, 38(5):2650-2658.
59. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. Journal of Neuroscience 1993, 13(9):3839-3847.
60. Dong E., Agis-Balboa R.C., Simonini M.V., Grayson D.R., Costa E., Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(35):12578-12583.
61. Drevets W.C. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology 2001, 11(2):240-249.
62. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Structure and Function 2008, 213(1-2):93-118.
63. Drugan R.C., Morrow A.L., Weizman R., Weizman A., Deutsch S.I., Crawley J.N., et al. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Research 1989, 487(1):45-51.
64. Duman R.S., Aghajanian G.K. Synaptic dysfunction in depression: Potential therapeutic targets. Science 2012, 338(6103):68-72.
65. Duman R.S., Li N. A neurotrophic hypothesis of depression: Role of synaptogenesis in the actions of NMDA receptor antagonists. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2012, 367(1601):2475-2484.
66. Duman R.S., Malberg J., Nakagawa S. Regulation of adult neurogenesis by psychotropic drugs and stress. Journal of Pharmacol and Experimental Therapeutics 2001, 299(2):401-407.
67. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 2006, 59(12):1116-1127.
68. Duman C.H., Schlesinger L., Kodama M., Russell D.S., Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biological Psychiatry 2007, 61(5):661-670.
69. Duric V., Banasr M., Licznerski P., Schmidt H.D., Stockmeier C.A., Simen A.A., et al. A negative regulator of MAP kinase causes depressive behavior. Nature Medicine 2010, 16(11):1328-1332.
70. A receptor-mediated regulation of adult hippocampal neurogenesis. European Journal of Neuroscience 2011, 34(3):362-373.
71. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 2003, 60(8):804-815.
72. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. Journal of Neurochemistry 2001, 77(3):916-928.
73. Dwivedi Y., Rizavi H.S., Teppen T., Sasaki N., Chen H., Zhang H., et al. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects. Neuropsychopharmacology 2007, 32(11):2338-2350.
74. Dwivedi Y., Rizavi H.S., Zhang H., Mondal A.C., Roberts R.C., Conley R.R., et al. Neurotrophin receptor activation and expression in human postmortem brain: Effect of suicide. Biological Psychiatry 2009, 65(4):319-328.
75. Dwivedi Y., Rizavi H.S., Zhang H., Roberts R.C., Conley R.R., Pandey G.N. Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: Further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide subjects. Biological Psychiatry 2010, 67(11):1017-1025.
76. Earnheart J.C., Schweizer C., Crestani F., Iwasato T., Itohara S., Mohler H., et al. GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. Journal of Neuroscience 2007, 27(14):3845-3854.
77. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112(2):257-269.
78. Eisch A.J., Bolanos C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: A role in depression. Biological Psychiatry 2003, 54(10):994-1005.
79. A receptor subtypes requires the gamma2 subunit and gephyrin. Nature Neuroscience 1998, 1(7):563-571.
80. Fava M., Rush A.J., Alpert J.E., Balasubramani G.K., Wisniewski S.R., Carmin C.N., et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. The American Journal of Psychiatry 2008, 165(3):342-351.
81. Feyissa A.M., Woolverton W.L., Miguel-Hidalgo J.J., Wang Z., Kyle P.B., Hasler G., et al. Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 2010, 34(2):279-283.
82. Fiszman M.L., Schousboe A. Role of calcium and kinases on the neurotrophic effect induced by gamma-aminobutyric acid. Journal of Neuroscience Research 2004, 76(4):435-441.
83. Fiumelli H., Woodin M.A. Role of activity-dependent regulation of neuronal chloride homeostasis in development. Current Opinion in Neurobiology 2007, 17(1):81-86.
84. Flint J., Kendler K.S. The genetics of major depression. Neuron 2014, 81(3):484-503.
85. Franklin T.B., Russig H., Weiss I.C., Graff J., Linder N., Michalon A., et al. Epigenetic transmission of the impact of early stress across generations. Biological Psychiatry 2010, 68(5):408-415.
86. A receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits. Journal of Comparative Neurology 1995, 359:154-194.
87. Fujii T., Saito D.N., Yanaka H.T., Kosaka H., Okazawa H. Depressive mood modulates the anterior lateral CA1 and DG/CA3 during a pattern separation task in cognitively intact individuals: A functional MRI study. Hippocampus 2014, 24(2):214-224.
88. Fujioka T., Fujioka A., Duman R.S. Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. Journal of Neuroscience 2004, 24(2):319-328.
89. Gabbay V., Mao X., Klein R.G., Ely B.A., Babb J.S., Panzer A.M., et al. Anterior cingulate cortex gamma-aminobutyric acid in depressed adolescents: Relationship to anhedonia. Archives of General Psychiatry 2012, 69(2):139-149.
90. Gamez W., Watson D., Doebbeling B.N. Abnormal personality and the mood and anxiety disorders: Implications for structural models of anxiety and depression. Journal of Anxiety Disorders 2007, 21(4):526-539.
91. Garcia L.S., Comim C.M., Valvassori S.S., Reus G.Z., Stertz L., Kapczinski F., et al. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33(3):450-455.
92. Gascon E., Dayer A.G., Sauvain M.O., Potter G., Jenny B., De Roo M., et al. GABA regulates dendritic growth by stabilizing lamellipodia in newly generated interneurons of the olfactory bulb. Journal of Neuroscience 2006, 26(50):12956-12966.
93. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofield P.R., et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Molecular Psychiatry 2009, 14(7):681-695.
94. Ge S., Pradhan D.A., Ming G.L., Song H. GABA sets the tempo for activity-dependent adult neurogenesis. Trends in Neurosciences 2007, 30(1):1-8.
95. Gilabert-Juan J., Castillo-Gomez E., Guirado R., Molto M.D., Nacher J. Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice. Brain Structure and Function 2013, 218(6):1591-1605.
96. Goren M.Z., Kucukibrahimoglu E., Berkman K., Terzioglu B. Fluoxetine partly exerts its actions through GABA: A neurochemical evidence. Neurochemical Research 2007, 32(9):1559-1565.
97. Gorman J.M. Comorbid depression and anxiety spectrum disorders. Depression and Anxiety 1996, 4(4):160-168.
98. Gould E., Tanapat P. Stress and hippocampal neurogenesis. Biological Psychiatry 1999, 46(11):1472-1479.
99. Gourley S.L., Wu F.J., Kiraly D.D., Ploski J.E., Kedves A.T., Duman R.S., et al. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biological Psychiatry 2008, 63(4):353-359.
100. Gronli J., Bramham C., Murison R., Kanhema T., Fiske E., Bjorvatn B., et al. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacology, Biochemistry, and Behavior 2006, 85(4):842-849.
101. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., et al. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behavioural Brain Research 2007, 181(1):42-51.
102. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416(6879):396-400.
103. Groth R.D., Mermelstein P.G. Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: A role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. Journal of Neuroscience 2003, 23(22):8125-8134.
104. Guerry J.D., Hastings P.D. In search of HPA axis dysregulation in child and adolescent depression. Clinical Child and Family Psychology Review 2011, 14(2):135-160.
105. Guilloux J.P., Douillard-Guilloux G., Kota R., Wang X., Gardier A.M., Martinowich K., et al. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Molecular Psychiatry 2012, 17(11):1130-1142.
106. Guillozet-Bongaarts A.L., Hyde T.M., Dalley R.A., Hawrylycz M.J., Henry A., Hof P.R., et al. Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Molecular Psychiatry 2014, 19(4):478-485.
107. Gunn B.G., Cunningham L., Cooper M.A., Corteen N.L., Seifi M., Swinny J.D., et al. Dysfunctional astrocytic and synaptic regulation of hypothalamic glutamatergic transmission in a mouse model of early-life adversity: Relevance to neurosteroids and programming of the stress response. Journal of Neuroscience 2013, 33(50):19534-19554.
108. Gunn B.G., Cunningham L., Mitchell S.G., Swinny J.D., Lambert J.J., Belelli D. GABA receptor-acting neurosteroids: A role in the development and regulation of the stress response. Frontiers in Neuroendocrinology 2014, in press. 10.1016/j.yfrne.2014.06.001.
109. Gur T.L., Conti A.C., Holden J., Bechtholt A.J., Hill T.E., Lucki I., et al. cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. Journal of Neuroscience 2007, 27(29):7860-7868.
110. Guthrie C.R., Murray A.T., Franklin A.A., Hamblin M.W. Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. Journal of Pharmacol and Experimental Therapeutics 2005, 313(3):1003-1010.
111. Hardingham G.E., Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders. Nature Reviews. Neuroscience 2010, 11(10):682-696.
112. Hashimoto K., Sawa A., Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biological Psychiatry 2007, 62(11):1310-1316.
113. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. Journal of Neuroscience 2003, 23(15):6315-6326.
114. Hasin D.S., Goodwin R.D., Stinson F.S., Grant B.F. Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry 2005, 62(10):1097-1106.
115. Hasler G., van der Veen J.W., Grillon C., Drevets W.C., Shen J. Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy. The American Journal of Psychiatry 2010, 167(10):1226-1231.
116. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Archives of General Psychiatry 2007, 64(2):193-200.
117. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(25):15049-15054.
118. Hek K., Demirkan A., Lahti J., Terracciano A., Teumer A., Cornelis M.C., et al. A genome-wide association study of depressive symptoms. Biological Psychiatry 2013, 73(7):667-678.
119. Herman J.P., Cullinan W.E., Morano M.I., Akil H., Watson S.J. Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. Journal of Neuroendocrinology 1995, 7(6):475-482.
120. Hewitt S.A., Wamsteeker J.I., Kurz E.U., Bains J.S. Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis. Nature Neuroscience 2009, 12(4):438-443.
121. Hickie I., Naismith S., Ward P.B., Turner K., Scott E., Mitchell P., et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. The British Journal of Psychiatry 2005, 186:197-202.
122. Holm M.M., Nieto-Gonzalez J.L., Vardya I., Henningsen K., Jayatissa M.N., Wiborg O., et al. Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Hippocampus 2011, 21(4):422-433.
123. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: Implications for therapy. Journal of Affective Disorders 2001, 62(1-2):77-91.
124. Holtzheimer P.E., Mayberg H.S. Deep brain stimulation for psychiatric disorders. Annual Review of Neuroscience 2011, 34:289-307.
125. Hong E.J., McCord A.E., Greenberg M.E. A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition. Neuron 2008, 60(4):610-624.
126. Hu W., Zhang M., Czeh B., Flugge G., Zhang W. Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network. Neuropsychopharmacology 2010, 35(8):1693-1707.
127. Huang Z.J., Kirkwood A., Pizzorusso T., Porciatti V., Morales B., Bear M.F., et al. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 1999, 98(6):739-755.
128. Inoue W., Baimoukhametova D.V., Fuzesi T., Cusulin J.I., Koblinger K., Whelan P.J., et al. Noradrenaline is a stress-associated metaplastic signal at GABA synapses. Nature Neuroscience 2013, 16(5):605-612.
129. Jackson K., Soutto M., Peng D., Hu T., Marshal D., El-Rifai W. Epigenetic silencing of somatostatin in gastric cancer. Digestive Diseases and Sciences 2011, 56(1):125-130.
130. A receptor trafficking and decreases synaptic inhibition. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(45):18595-18600.
131. A receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nature Reviews. Neuroscience 2008, 9(5):331-343.
132. A receptor subunit mRNA expression. Neuroscience 2012, 215:114-126.
133. Jagasia R., Steib K., Englberger E., Herold S., Faus-Kessler T., Saxe M., et al. GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus. Journal of Neuroscience 2009, 29(25):7966-7977.
134. Jovanovic J.N., Czernik A.J., Fienberg A.A., Greengard P., Sihra T.S. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nature Neuroscience 2000, 3(4):323-329.
135. A receptor gamma2 subunit. Molecular and Cellular Neuroscience 2010, 44(2):129-134.
136. Kang H.J., Voleti B., Hajszan T., Rajkowska G., Stockmeier C.A., Licznerski P., et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nature Medicine 2012, 18(9):1413-1417.
137. Karolewicz B., Maciag D., O'Dwyer G., Stockmeier C.A., Feyissa A.M., Rajkowska G. Reduced level of glutamic acid decarboxylase-67kDa in the prefrontal cortex in major depression. International Journal of Neuropsychopharmacology 2010, 13(4):411-420.
138. Karpova N.N. Role of BDNF epigenetics in activity-dependent neuronal plasticity. Neuropharmacology 2014, 76 Pt C:709-718.
139. Karten Y.J., Olariu A., Cameron H.A. Stress in early life inhibits neurogenesis in adulthood. Trends in Neurosciences 2005, 28(4):171-172.
140. Kathol R.G., Jaeckle R.S., Lopez J.F., Meller W.H. Pathophysiology of HPA axis abnormalities in patients with major depression: An update. The American Journal of Psychiatry 1989, 146(3):311-317.
141. Kaufman R.E., Ostacher M.J., Marks E.H., Simon N.M., Sachs G.S., Jensen J.E., et al. Brain GABA levels in patients with bipolar disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33(3):427-434.
142. Keller M.B., McCullough J.P., Klein D.N., Arnow B., Dunner D.L., Gelenberg A.J., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 2000, 342(20):1462-1470.
143. Kendler K.S., Gatz M., Gardner C.O., Pedersen N.L. A Swedish national twin study of lifetime major depression. The American Journal of Psychiatry 2006, 163(1):109-114.
144. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. The American Journal of Psychiatry 1999, 156(6):837-841.
145. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289(23):3095-3105.
146. Khan A., Khan S.R., Walens G., Kolts R., Giller E.L. Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: An analysis of the food and drug administration summary basis of approval reports. Neuropsychopharmacology 2003, 28(3):552-557.
147. Kheirbek M.A., Klemenhagen K.C., Sahay A., Hen R. Neurogenesis and generalization: A new approach to stratify and treat anxiety disorders. Nature Neuroscience 2012, 15(12):1613-1620.
148. Kim S.J., Cho S.J., Jang H.M., Shin J., Park P.W., Lee Y.J., et al. Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology 2010, 61(1):19-26.
149. Kim Y.K., Lee H.P., Won S.D., Park E.Y., Lee H.Y., Lee B.H., et al. Low plasma BDNF is associated with suicidal behavior in major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 2007, 31(1):78-85.
150. A receptor gamma2 subunit. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(9):3616-3621.
151. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., ffrench-Mullen J., et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Molecular Psychiatry 2009, 14(2):175-189.
152. Klempin F., Babu H., De Pietri Tonelli D., Alarcon E., Fabel K., Kempermann G. Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Frontiers in Molecular Neuroscience 2010, 3(14).
153. Klempin F., Beis D., Mosienko V., Kempermann G., Bader M., Alenina N. Serotonin is required for exercise-induced adult hippocampal neurogenesis. Journal of Neuroscience 2013, 33(19):8270-8275.
154. 11C]flumazenil binding in major depression: Preliminary results. European Journal of Nuclear Medicine and Molecular Imaging 2010, 37(3):565-574.
155. A receptor clustering in gephyrin-deficient mice. Journal of Neuroscience 1999, 19(21):9289-9297.
156. Kohara K., Kitamura A., Adachi N., Nishida M., Itami C., Nakamura S., et al. Inhibitory but not excitatory cortical neurons require presynaptic brain-derived neurotrophic factor for dendritic development, as revealed by chimera cell culture. Journal of Neuroscience 2003, 23(14):6123-6131.
157. Koolschijn P.C., van Haren N.E., Lensvelt-Mulders G.J., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies. Human Brain Mapping 2009, 30(11):3719-3735.
158. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455(7215):894-902.
159. Krystal J.H., Sanacora G., Duman R.S. Rapid-acting glutamatergic antidepressants: The path to ketamine and beyond. Biological Psychiatry 2013, 73(12):1133-1141.
160. Kucukibrahimoglu E., Saygin M.Z., Caliskan M., Kaplan O.K., Unsal C., Goren M.Z. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. European Journal of Clinical Pharmacology 2009, 65(6):571-577.
161. Lagace D.C., Donovan M.H., DeCarolis N.A., Farnbauch L.A., Malhotra S., Berton O., et al. Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(9):4436-4441.
162. Lan M.J., McLoughlin G.A., Griffin J.L., Tsang T.M., Huang J.T., Yuan P., et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Molecular Psychiatry 2009, 14(3):269-279.
163. Leal S.L., Tighe S.K., Jones C.K., Yassa M.A. Pattern separation of emotional information in hippocampal dentate and CA3. Hippocampus 2014, 24(9):1146-1155.
164. A receptor-mediated currents. Nature Neuroscience 2011, 14(6):736-743.
165. Lee V., Sarkar J., Maguire J. Loss of Gabrd in CRH neurons blunts the corticosterone response to stress and diminishes stress-related behaviors. Psychoneuroendocrinology 2014, 41:75-88.
166. Levinson A.J., Fitzgerald P.B., Favalli G., Blumberger D.M., Daigle M., Daskalakis Z.J. Evidence of cortical inhibitory deficits in major depressive disorder. Biological Psychiatry 2010, 67(5):458-464.
167. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329(5994):959-964.
168. Li N., Liu R.J., Dwyer J.M., Banasr M., Lee B., Son H., et al. Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry 2011, 69(8):754-761.
169. Li H.Y., Sawchenko P.E. Hypothalamic effector neurons and extended circuitries activated in "neurogenic" stress: A comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels. Journal of Comparative Neurology 1998, 393(2):244-266.
170. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 2009, 373(9659):234-239.
171. Liu R.J., Fuchikami M., Dwyer J.M., Lepack A.E., Duman R.S., Aghajanian G.K. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology 2013, 38(11):2268-2277.
172. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290(5489):131-134.
173. Luscher B., Fuchs T. Adult hippocampal neurogenesis in the absence of serotonin (Commentary on Diaz et al.). European Journal of Neuroscience 2013, 38(5):2649.
174. A receptor trafficking-mediated plasticity of inhibitory synapses. Neuron 2011, 70(3):385-409.
175. Luscher B., Shen Q., Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Molecular Psychiatry 2011, 16(4):383-406.
176. Maciag D., Hughes J., O'Dwyer G., Pride Y., Stockmeier C.A., Sanacora G., et al. Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: Relevance to neuroimaging studies. Biological Psychiatry 2010, 67(5):465-470.
177. A receptors in affective disorders. Psychopharmacology 2014, 231(17):3333-3342.
178. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(3):1387-1392.
179. Maeng S., Zarate C.A., Du J., Schloesser R.J., McCammon J., Chen G., et al. Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biological Psychiatry 2008, 63(4):349-352.
180. Maes M., Verkerk R., Vandoolaeghe E., Lin A., Scharpe S. Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: Modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatrica Scandinavica 1998, 97(4):302-308.
181. Maggio N., Segal M. Differential corticosteroid modulation of inhibitory synaptic currents in the dorsal and ventral hippocampus. Journal of Neuroscience 2009, 29(9):2857-2866.
182. A receptor plasticity during pregnancy. Journal of Neuroscience 2009, 29(30):9592-9601.
183. A receptors: Relevance to the ovarian cycle and stress. Journal of Neuroscience 2007, 27(9):2155-2162.
184. AR plasticity during pregnancy: Relevance to postpartum depression. Neuron 2008, 59(2):207-213.
185. A receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nature Neuroscience 2005, 8(6):797-804.
186. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S., Wray N.R., Lewis C.M., Hamilton S.P., Weissman M.M. A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry 2013, 18(4):497-511.
187. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 2000, 20(24):9104-9110.
188. A autoreceptor/Cl- channels. Journal of Neuroscience 2001, 21(7):2343-2360.
189. Martisova E., Solas M., Horrillo I., Ortega J.E., Meana J.J., Tordera R.M., et al. Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus. Neuropharmacology 2012, 62(5-6):1944-1953.
190. Matussek N. Die catecholamin- und serotoninhypothese der depression. Das depressive syndrome 1969, Urban & Schwarzenberg, München, Berlin, Wien. H. Hippius, H. Seebach (Eds.).
191. A receptor subunits in frontal cortical brain region. Journal of Neuroscience 2004, 24(6):1478-1485.
192. Miguel-Hidalgo J.J., Rajkowska G. Morphological brain changes in depression: Can antidepressants reverse them?. CNS Drugs 2002, 16(6):361-372.
193. Miguel-Hidalgo J.J., Waltzer R., Whittom A.A., Austin M.C., Rajkowska G., Stockmeier C.A. Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. Journal of Affective Disorders 2010, 127(1-3):230-240.
194. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., et al. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(22):12905-12910.
195. Mineur Y.S., Obayemi A., Wigestrand M.B., Fote G.M., Calarco C.A., Li A.M., et al. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(9):3573-3578.
196. Mirescu C., Peters J.D., Gould E. Early life experience alters response of adult neurogenesis to stress. Nature Neuroscience 2004, 7(8):841-846.
197. Mitani H., Shirayama Y., Yamada T., Maeda K., Ashby C.R., Kawahara R. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 2006, 30(6):1155-1158.
198. A receptors induced by brain-derived neurotrophic factor in rat visual cortex. Journal of Biological Chemistry 2003, 278(45):44097-44102.
199. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62(1):42-53.
200. Morris H.M., Hashimoto T., Lewis D.A. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cerebral Cortex 2008, 18(7):1575-1587.
201. Murray C.J., Lopez A.D. Evidence-based health policy-Lessons from the Global Burden of Disease Study. Science 1996, 274(5288):740-743.
202. Murray E.A., Wise S.P., Drevets W.C. Localization of dysfunction in major depressive disorder: Prefrontal cortex and amygdala. Biological Psychiatry 2011, 69(12):e43-54.
203. Nakagawa S., Kim J.E., Lee R., Malberg J.E., Chen J., Steffen C., et al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. Journal of Neuroscience 2002, 22(9):3673-3682.
204. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 1995, 15(11):7539-7547.
205. Okamoto H., Voleti B., Banasr M., Sarhan M., Duric V., Girgenti M.J., et al. Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biological Psychiatry 2010, 68(6):521-527.
206. Ongur D., Prescot A.P., McCarthy J., Cohen B.M., Renshaw P.F. Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biological Psychiatry 2010, 68(7):667-670.
207. Otero Losada M.E. Changes in central GABAergic function following acute and repeated stress. British Journal of Pharmacology 1988, 93(3):483-490.
208. Papouin T., Ladepeche L., Ruel J., Sacchi S., Labasque M., Hanini M., et al. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell 2012, 150(3):633-646.
209. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(18):10734-10739.
210. Paul I.A., Skolnick P. Glutamate and depression: Clinical and preclinical studies. Annals of the New York Academy of Sciences 2003, 1003:250-272.
211. Perroud N., Courtet P., Vincze I., Jaussent I., Jollant F., Bellivier F., et al. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes, Brain, and Behavior 2008, 7(3):314-322.
212. Perry P.J. Pharmacotherapy for major depression with melancholic features: Relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of Affective Disorders 1996, 39(1):1-6.
213. Petrik D., Lagace D.C., Eisch A.J. The neurogenesis hypothesis of affective and anxiety disorders: Are we mistaking the scaffolding for the building?. Neuropharmacology 2012, 62(1):21-34.
214. Petty F., Trivedi M.H., Fulton M., Rush A.J. Benzodiazepines as antidepressants: Does GABA play a role in depression?. Biological Psychiatry 1995, 38(9):578-591.
215. Pinna G., Costa E., Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology 2006, 186(3):362-372.
216. Pinna G., Costa E., Guidotti A. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Current Opinion in Pharmacology 2009, 9(1):24-30.
217. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 2008, 33(1):88-109.
218. A) receptor signaling and brain-derived neurotrophic factor (BDNF) release in developing neurons. Journal of Biological Chemistry 2011, 286(24):21667-21677.
219. A receptor promoter hypermethylation in suicide brain: Implications for the involvement of epigenetic processes. Biological Psychiatry 2008, 64(8):645-652.
220. Preskorn S.H., Baker B., Kolluri S., Menniti F.S., Krams M., Landen J.W. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. Journal of Clinical Psychopharmacology 2008, 28(6):631-637.
221. Quadrato G., Benevento M., Alber S., Jacob C., Floriddia E.M., Nguyen T., et al. Nuclear factor of activated T cells (NFATc4) is required for BDNF-dependent survival of adult-born neurons and spatial memory formation in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(23):E1499-1508.
222. A receptor signaling increases neurogenesis and suppresses anxiety through NFATc4. Journal of Neuroscience 2014, 34(25):8630-8645.
223. Radley J.J., Gosselink K.L., Sawchenko P.E. A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. Journal of Neuroscience 2009, 29(22):7330-7340.
224. Raison C.L., Borisov A.S., Majer M., Drake D.F., Pagnoni G., Woolwine B.J., et al. Activation of central nervous system inflammatory pathways by interferon-alpha: Relationship to monoamines and depression. Biological Psychiatry 2009, 65(4):296-303.
225. Rajkowska G., Miguel-Hidalgo J.J. Gliogenesis and glial pathology in depression. CNS & Neurological Disorders Drug Targets 2007, 6(3):219-233.
226. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007, 32(2):471-482.
227. A receptor-deficient mice. Neuropharmacology 2014, (Epub ahead of print). 10.1016/j.neuropharm.2014.07.019.
228. Represa A., Ben-Ari Y. Trophic actions of GABA on neuronal development. Trends in Neurosciences 2005, 28(6):278-283.
229. 18F]MPPF in the nucleus raphe dorsalis of rat. Journal of Neuroscience 2004, 24(23):5420-5426.
230. Rico B., Xu B., Reichardt L.F. TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum. Nature Neuroscience 2002, 5(3):225-233.
231. Roose S.P., Glassman A.H., Attia E., Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. The American Journal of Psychiatry 1994, 151(12):1735-1739.
232. Rosenzweig-Lipson S., Sabb A., Stack G., Mitchell P., Lucki I., Malberg J.E., et al. Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents. Psychopharmacology 2007, 192(2):159-170.
233. Rossignol E. Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plasticity 2011, 2011:649325.
234. Roth T.L., Lubin F.D., Funk A.J., Sweatt J.D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biological Psychiatry 2009, 65(9):760-769.
235. Rowland L.M., Kontson K., West J., Edden R.A., Zhu H., Wijtenburg S.A., et al. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophrenia Bulletin 2013, 39(5):1096-1104.
236. Rubio A., Sanchez-Mut J.V., Garcia E., Velasquez Z.D., Oliver J., Esteller M., et al. Epigenetic control of somatostatin and cortistatin expression by beta amyloid peptide. Journal of Neuroscience Research 2012, 90(1):13-20.
237. A receptor subtypes: Therapeutic potential in down syndrome, affective disorders, schizophrenia, and autism. Annual Review of Pharmacology and Toxicology 2014, 54:483-507.
238. Ruhe H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Molecular Psychiatry 2007, 12(4):331-359.
239. Russo S.J., Nestler E.J. The brain reward circuitry in mood disorders. Nature Reviews. Neuroscience 2013, 14(9):609-625.
240. Russo-Neustadt A.A., Chen M.J. Brain-derived neurotrophic factor and antidepressant activity. Current Pharmaceutical Design 2005, 11(12):1495-1510.
241. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. Journal of Neuroscience 2003, 23(1):349-357.
242. Sacher J., Neumann J., Funfstuck T., Soliman A., Villringer A., Schroeter M.L. Mapping the depressed brain: A meta-analysis of structural and functional alterations in major depressive disorder. Journal of Affective Disorders 2012, 140(2):142-148.
243. Sahay A., Scobie K.N., Hill A.S., O'Carroll C.M., Kheirbek M.A., Burghardt N.S., et al. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 2011, 472(7344):466-470.
244. Sairanen M., Lucas G., Ernfors P., Castren M., Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. Journal of Neuroscience 2005, 25(5):1089-1094.
245. Sakata K., Jin L., Jha S. Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes, Brain, and Behavior 2010, 9(7):712-721.
246. Sakata K., Woo N.H., Martinowich K., Greene J.S., Schloesser R.J., Shen L., et al. Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(14):5942-5947.
247. Samuels B.A., Hen R. Neurogenesis and affective disorders. European Journal of Neuroscience 2011, 33(6):1152-1159.
248. Samuels B.A., Leonardo E.D., Gadient R., Williams A., Zhou J., David D.J., et al. Modeling treatment-resistant depression. Neuropharmacology 2011, 61(3):408-413.
249. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry 2004, 61(7):705-713.
250. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Archives of General Psychiatry 1999, 56(11):1043-1047.
251. Sanacora G., Mason G.F., Rothman D.L., Hyder F., Ciarcia J.J., Ostroff R.B., et al. Increased cortical GABA concentrations in depressed patients receiving ECT. The American Journal of Psychiatry 2003, 160(3):577-579.
252. Sanacora G., Mason G.F., Rothman D.L., Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. The American Journal of Psychiatry 2002, 159(4):663-665.
253. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301(5634):805-809.
254. Sapolsky R.M., Krey L.C., McEwen B.S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proceedings of the National Academy of Sciences of the United States of America 1984, 81(19):6174-6177.
255. A receptors. Journal of Neuroscience 2011, 31(50):18198-18210.
256. Savitz J.B., Drevets W.C. Imaging phenotypes of major depressive disorder: Genetic correlates. Neuroscience 2009, 164(1):300-330.
257. Schildkraut J. The catecholamine hypothesis of affective disorders: A review of supporting evidence. The American Journal of Psychiatry 1965, 122:509-522.
258. Schildkraut J.J. The catecholamine hypothesis of affective disorders: A review of supporting evidence. 1965. Journal of Neuropsychiatry and Clinical Neurosciences 1995, 7(4):524-533. (Discussion 523-524).
259. Schlag B.D., Lou Z., Fennell M., Dunlop J. Ligand dependency of 5-hydroxytryptamine 2C receptor internalization. Journal of Pharmacol and Experimental Therapeutics 2004, 310(3):865-870.
260. Schloesser R.J., Manji H.K., Martinowich K. Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response. Neuroreport 2009, 20(6):553-557.
261. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioral Pharmacology 2007, 18(5-6):391-418.
262. Schmidt-Hieber C., Jonas P., Bischofberger J. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature 2004, 429(6988):184-187.
263. Schreiber G., Avissar S. Regulators of G-protein-coupled receptor-G-protein coupling: Antidepressants mechanism of action. Expert Review of Neurotherapeutics 2007, 7(1):75-84.
264. Sequeira A., Klempan T., Canetti L., ffrench-Mullen J., Benkelfat C., Rouleau G.A., et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Molecular Psychiatry 2007, 12(7):640-655.
265. Sequeira A., Mamdani F., Ernst C., Vawter M.P., Bunney W.E., Lebel V., et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009, 4(8):e6585.
266. A receptor plasticity and function. Brain Research Reviews 2008, 57(2):520-530.
267. Shaywitz A.J., Greenberg M.E. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annual Review of Biochemistry 1999, 68:821-861.
268. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. The American Journal of Psychiatry 2003, 160(8):1516-1518.
269. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. Journal of Neuroscience 1999, 19(12):5034-5043.
270. Shelton R.C., Claiborne J., Sidoryk-Wegrzynowicz M., Reddy R., Aschner M., Lewis D.A., et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Molecular Psychiatry 2011, 16:751-762.
271. Shen Q., Lal R., Luellen B.A., Earnheart J.C., Andrews A.M., Luscher B. gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biological Psychiatry 2010, 68(6):512-520.
272. Shieh P.B., Hu S.C., Bobb K., Timmusk T., Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998, 20(4):727-740.
273. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 2003, 54(1):70-75.
274. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 2002, 22(8):3251-3261.
275. Si X., Miguel-Hidalgo J.J., O'Dwyer G., Stockmeier C.A., Rajkowska G. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 2004, 29(11):2088-2096.
276. Sibille E., Morris H.M., Kota R.S., Lewis D.A. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. International Journal of Neuropsychopharmacology 2011, 14(6):721-734.
277. A receptor subtypes. Neuropharmacology 2012, 62(1):54-62.
278. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476(7361):458-461.
279. Song J., Zhong C., Bonaguidi M.A., Sun G.J., Hsu D., Gu Y., et al. Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision. Nature 2012, 489(7414):150-154.
280. Stander V.A., Thomsen C.J., Highfill-McRoy R.M. Etiology of depression comorbidity in combat-related PTSD: A review of the literature. Clinical Psychology Review 2014, 34(2):87-98.
281. Steffens D.C., Byrum C.E., McQuoid D.R., Greenberg D.L., Payne M.E., Blitchington T.F., et al. Hippocampal volume in geriatric depression. Biological Psychiatry 2000, 48(4):301-309.
282. A receptors. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(24):14439-14444.
283. Suchanek R., Owczarek A., Paul-Samojedny M., Kowalczyk M., Kucia K., Kowalski J. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population. Journal of Neuropsychiatry and Clinical Neurosciences 2013, 25(1):88-94.
284. Sullivan R.M., Gratton A. Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats. Journal of Neuroscience 1999, 19(7):2834-2840.
285. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Archives of General Psychiatry 2003, 60(12):1187-1192.
286. Surget A., Tanti A., Leonardo E.D., Laugeray A., Rainer Q., Touma C., et al. Antidepressants recruit new neurons to improve stress response regulation. Molecular Psychiatry 2011, 16(12):1177-1188.
287. Swartz C.M., Guadagno G. Melancholia with onset during treatment with SSRIs. Annals of Clinical Psychiatry 1998, 10(4):177-179.
288. Taliaz D., Stall N., Dar D.E., Zangen A. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Molecular Psychiatry 2010, 15(1):80-92.
289. Tan K.R., Yvon C., Turiault M., Mirzabekov J.J., Doehner J., Labouebe G., et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 2012, 73(6):1173-1183.
290. Tan H., Zhong P., Yan Z. Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. Journal of Neuroscience 2004, 24(21):5000-5008.
291. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20(4):709-726.
292. Tashiro A., Sandler V.M., Toni N., Zhao C., Gage F.H. NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus. Nature 2006, 442(7105):929-933.
293. Tayoshi S., Nakataki M., Sumitani S., Taniguchi K., Shibuya-Tayoshi S., Numata S., et al. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study. Schizophrenia Research 2010, 117(1):83-91.
294. Tokita K., Yamaji T., Hashimoto K. Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacology, Biochemistry, and Behavior 2012, 100(4):688-704.
295. Toth M. 5-HT1A receptor knockout mouse as a genetic model of anxiety. European Journal of Pharmacology 2003, 463(1-3):177-184.
296. Tretter V., Revilla-Sanchez R., Houston C., Terunuma M., Havekes R., Florian C., et al. Deficits in spatial memory correlate with modified {gamma}-aminobutyric acid type A receptor tyrosine phosphorylation in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(47):20039-20044.
297. Tripp A., Kota R.S., Lewis D.A., Sibille E. Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiology of Disease 2011, 42(1):116-124.
298. Tripp A., Oh H., Guilloux J.P., Martinowich K., Lewis D.A., Sibille E. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. The American Journal of Psychiatry 2012, 169(11):1194-1202.
299. Tritsch N.X., Ding J.B., Sabatini B.L. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 2012, 490(7419):262-266.
300. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. European Journal of Pharmacology 1990, 185(1):1-10.
301. Tyagarajan S.K., Fritschy J.M. Gephyrin: A master regulator of neuronal function?. Nature Reviews. Neuroscience 2014, 15(3):141-156.
302. Tyagarajan S.K., Ghosh H., Harvey K., Fritschy J.M. Collybistin splice variants differentially interact with gephyrin and Cdc42 to regulate gephyrin clustering at GABAergic synapses. Journal of Cell Science 2011, 124(Pt 16):2786-2796.
303. Tyagarajan S.K., Ghosh H., Yevenes G.E., Imanishi S.Y., Zeilhofer H.U., Gerrits B., et al. Extracellular signal-regulated kinase and glycogen synthase kinase 3beta regulate gephyrin postsynaptic aggregation and GABAergic synaptic function in a calpain-dependent mechanism. Journal of Biological Chemistry 2013, 288(14):9634-9647.
304. Tyagarajan S.K., Ghosh H., Yevenes G.E., Nikonenko I., Ebeling C., Schwerdel C., et al. Regulation of GABAergic synapse formation and plasticity by GSK3 beta-dependent phosphorylation of gephyrin. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(1):379-384.
305. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(22):12599-12604.
306. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(6):3239-3244.
307. van Zessen R., Phillips J.L., Budygin E.A., Stuber G.D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 2012, 73(6):1184-1194.
308. Verkuyl J.M., Hemby S.E., Joels M. Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. The European Journal of Neuroscience 2004, 20(6):1665-1673.
309. A receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons. Neuropharmacology 2002, 43(4):646-650.
310. A receptor alpha subunits differentially contribute to diazepam tolerance after chronic treatment. PLoS One 2012, 7(8):e43054.
311. A-receptor gamma2 subunit. Journal of Neuroscience 2013, 33(39):15567-15577.
312. Voleti B., Duman R.S. The roles of neurotrophic factor and Wnt signaling in depression. Clinical Pharmacology and Therapeutics 2012, 91(2):333-338.
313. A receptors. Behavioural Brain Research 2011, 217(1):77-80.
314. Walker A.K., Kavelaars A., Heijnen C.J., Dantzer R. Neuroinflammation and comorbidity of pain and depression. Pharmacological Reviews 2014, 66(1):80-101.
315. Wardle R.A., Poo M.M. Brain-derived neurotrophic factor modulation of GABAergic synapses by postsynaptic regulation of chloride transport. Journal of Neuroscience 2003, 23(25):8722-8732.
316. Waterhouse E.G., An J.J., Orefice L.L., Baydyuk M., Liao G.Y., Zheng K., et al. BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission. Journal of Neuroscience 2012, 32(41):14318-14330.
317. Weizman R., Weizman A., Kook K.A., Vocci F., Deutsch S.I., Paul S.M. Repeated swim stress alters brain benzodiazepine receptors measured in vivo. Journal of Pharmacology and Experimental Therapeutics 1989, 249(3):701-707.
318. World Health Organization The global burden of disease: 2004 update 2008, Available at. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.2014.
319. Young E.A., Altemus M., Lopez J.F., Kocsis J.H., Schatzberg A.F., DeBattista C., et al. HPA axis activation in major depression and response to fluoxetine: A pilot study. Psychoneuroendocrinology 2004, 29(9):1198-1204.
320. Yu H., Wang D.D., Wang Y., Liu T., Lee F.S., Chen Z.Y. Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. Journal of Neuroscience 2012, 32(12):4092-4101.
321. Yuen E.Y., Liu W., Karatsoreos I.N., Ren Y., Feng J., McEwen B.S., et al. Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Molecular Psychiatry 2011, 16(2):156-170.
322. Yuen E.Y., Wei J., Liu W., Zhong P., Li X., Yan Z. Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron 2012, 73(5):962-977.
323. Zattoni M., Mura M.L., Deprez F., Schwendener R.A., Engelhardt B., Frei K., et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. Journal of Neuroscience 2011, 31(11):4037-4050.
324. Zhang T.Y., Hellstrom I.C., Bagot R.C., Wen X., Diorio J., Meaney M.J. Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus. Journal of Neuroscience 2010, 30(39):13130-13137.
325. Zhao C., Wang F., Pun F.W., Mei L., Ren L., Yu Z., et al. Epigenetic regulation on GABRB2 isoforms expression: Developmental variations and disruptions in psychotic disorders. Schizophrenia Research 2012, 134(2-3):260-266.